Figure 2From: Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study Kaplan-Meier estimations of the probability (with 95% confidence intervals) to be free of adverse events after initiating a first-line antiretroviral therapy. Back to article page